[Federal Register Volume 63, Number 93 (Thursday, May 14, 1998)]
[Notices]
[Page 26816]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-12776]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Heart, Lung, and Blood Institute Special Emphasis Panel (SEP) 
meetings:

    Name of SEP: Endothelial Dysfunction in HIV Infection.
    Date: June 9-10, 1998.
    Time: 7:00 p.m.
    Place: Holiday Inn Gaithersburg, 2 Montgomery Village Avenue, 
Gaithersburg, Maryland 20879.
    Contact Person: Ramesh Vemuri, Ph.D., Two Rockledge Center, Room 
7194, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 
435-0476.
    Purpose/Agenda: To review and evaluate grant applications.

    Name of SEP: Molecular and Physical Characterization of the 
Vulnerable Plaque.
    Date: June 17-18, 1998.
    Time: 7:00 p.m.
    Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, 
Maryland 20814.
    Contact Person: Ivan Baines, Ph.D., Two Rockledge Center, Room 
7184, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 
435-0277.
    Purpose/Agenda: To review and evaluate grant applications.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health)

    Dated: May 7, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-12776 Filed 5-13-98; 8:45 am]
BILLING CODE 4140-01-M